Overview

Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Status:
Completed

Trial end date:
2019-07-08

Target enrollment:

Participant gender:

Summary

This study will evaluate the safety and efficacy of CTP-543 in adult patients with chronic, moderate to severe alopecia areata.

Phase:

Phase 2

Details

Lead Sponsor:

Concert Pharmaceuticals